Microsoft is known for shrouding its patent portfolio in secrecy, though reports have emerged in recent months that suggest Microsoft makes billions of dollars a year with its licensing agreements through Android. Now, reports say, new revelations released by financial advisor M-Cam suggest that a significant portion of Microsoft Android patents could be invalid.
M-Cam published the report on Microsoft in its Patently Obvious series and looked into China’s recent decision to publish a list of hundreds of Microsoft patents as part of its investigation into the company’s acquisition of Nokia. China’s Ministry of Commerce disclosed a list of 310 Microsoft patents last April.
”With this disclosure, China may be attempting to counteract Microsoft’s chokehold on the smartphone market. By disclosing the detailed list of these patents, companies who currently pay a license to Microsoft for the Android platform may discover that they have patents on the same technologies which precede Microsoft’s patents. This may create an opening for them to either negotiate a better deal or demand that Microsoft license from them,” M-Cam’s report said.
Further, analysis found that about one-fifth of Microsoft’s patent portfolio was directly commercially relevant.
Full content: i-Programmer
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FCC Set to Reinstate Net Neutrality Rules Today
Apr 25, 2024 by
CPI
Chamber of Commerce Sues to Overturn FTC Non-Compete Ban
Apr 24, 2024 by
CPI
FTC Chief Warns of Healthcare Price Fixing Risks Amid Tech Advancements
Apr 24, 2024 by
CPI
Amazon’s Investment in Anthropic Faces Antitrust Scrutiny
Apr 24, 2024 by
CPI
Italian Antitrust Authority Fines Amazon €10 Million for Unfair Trade Practices
Apr 24, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI